Reference
|
Number
|
Treatment
|
Proportion of patients with preserved ovarian function
|
Follow-up (Months)
|
---|
Leonard A Farber [3]
|
1
|
Radiotherapy + LOT+LAR
|
100%
|
13
|
Hodel et al. [7]
|
9
|
RH+LOT±XRT
|
78%
|
Ns
|
Husseinzadeh et al. [8]
|
22
|
RH+LOT
|
100%
|
Ns
|
14
|
LOT+XRT
|
67%
|
4
|
RH+LOT+XRT
|
50%
|
Chambers et al. [9]
|
54
|
RH
|
96%
|
54(median)
|
25
|
RH+LOT
|
96%
|
36(median)
|
Chambers et al. [10]
|
14
|
RH+LOT+ Radiotherapy
|
71%
|
35(median)
|
Feeney et al. [11]
|
58
|
RH+BSO±XRT
|
0%
|
24(mean)
|
104
|
RH+LOT
|
97%
|
28
|
RH+LOT+XRT
|
50%
|
Covens et al. [12]
|
3
|
PLND+LOT+XRT
|
66%
|
25-32
|
Van Eijkeren et al. [13]
|
36
|
RH+LOT
|
95%
|
36-48
|
18
|
RH+LOT+XRT
|
72%
|
Morice et al. [14]
|
11
|
RH+LOT
|
100%
|
31(median)
|
59
|
RH+LOT+Brachy
|
90%
|
35
|
RH+LOT+XRT+Brachy
|
60%
|
Yamamoto et al. [15]
|
30
|
RH+LOT
|
97/89%
|
At 12 v.s. At 60
|
26
|
RH+LOT+XRT
|
65/39%
|
Buekers et al. [16]
|
17
|
Radiotherapy + LOT ±RH
|
41%
|
At 12
|
Treissman MJ et al. [17]
|
1
|
Radiotherapy +LOT
|
50%
|
8
|
- RH radical hysterectomy, LOT lateral ovarian transposition, XRT external beam radiotherapy, BSO bilateral salpingo-oophorectomy, PLND pelvic lymph node dissection only, Brachy brachytherapy, Ns not stated.